ESSO 43 | Translating tumor microenvironment insights into personalized cancer therapies with nanotechnology

Gizem Öner • 4 Oct 2024

ESSO 43

Breast Cancer General

Gizem Öner, MD, Istanbul University, Istanbul, Türkiye, discusses research on how clinicians interpret preclinical studies in clinical practice, focusing on the tumor microenvironment (TME) and its impact on personalized cancer treatment. The research specifically investigates the role of macrophages (Mφ) in the TME, particularly their contribution to chemotherapy resistance. The study uses immunochemical analysis (CD68 and CD163 markers) to assess macrophage infiltration and its correlation with chemotherapy response. While promising, further research is needed to translate these findings into clinical practice.This interview took place at the ESSO 43 congress in Antwerp, Belgium.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.